US 8,268,847 B2
Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitorGeneral
US 8,268,847 B2
Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Sreeni Padmanabhan
Art Unit:
1627 Organic Chemistry
Agent:
Inventors:
Martine Clozel
Assignee:
Priority:
02/27/09
Filed:
08/28/07
Granted:
09/18/12
Expiration:
04/18/29
Abstract
The invention relates to a product containing the compound of formula (I) belowor a pharmaceutically acceptable salt of this compound, in combination with at least one compound having PDE5-inhibitory properties, or a pharmaceutically acceptable salt thereof, for therapeutic use, simultaneously, separately or over a period of time, in the treatment of a disease wherein vasoconstriction is involved.
Cooperative Patent Classification (CPC)
A61A61P11/00A61K2300/00A61P